PURPOSE: This study aims to provide external validation of the "Endoscopic Third Ventriculostomy Success Score (ETVSS)" for both short-term and long-term predictive adequacy. METHODS: Between 1998 and 2007, we collected clinical follow-up data (after 6 and 36 months) of all 104 hydrocephalic children (<18 years of age) treated by endoscopic third ventriculostomy (ETV) in our hospital. Predictive adequacy of ETVSS for 6- and 36-month periods was tested by means of an unpaired t test, Hosmer-Lemeshow "goodness-of- fit" test, and area under the receiver operating characteristic curve. RESULTS: Mean follow-up was 73.4 months. For both the short-term (6 months) and the long-term (36 months) periods, the mean predicted probability of ETV for the patients with successful ETV treatment was significantly higher than in the patients with failed ETV treatment. The areas under the curve for the short- and long-term periods were, respectively, 0.82 (95% CI 0.71-0.92) and 0.73 (95% CI 0.62-0.84). For patients with moderate ETVSS (50-70), the median age at first ETV was significantly higher for patients with successful ETV for both short- and long-term periods. CONCLUSION: In hydrocephalic children, the ETVSS is a useful tool for prediction of outcome after ETV treatment. The ETVSS is more adequate in predicting short-term than long-term success. In our population, it is suggested that success rate for patients with moderate ETVSS could be improved if more weight is attributed to age at first ETV.
PURPOSE: This study aims to provide external validation of the "Endoscopic Third Ventriculostomy Success Score (ETVSS)" for both short-term and long-term predictive adequacy. METHODS: Between 1998 and 2007, we collected clinical follow-up data (after 6 and 36 months) of all 104 hydrocephalic children (<18 years of age) treated by endoscopic third ventriculostomy (ETV) in our hospital. Predictive adequacy of ETVSS for 6- and 36-month periods was tested by means of an unpaired t test, Hosmer-Lemeshow "goodness-of- fit" test, and area under the receiver operating characteristic curve. RESULTS: Mean follow-up was 73.4 months. For both the short-term (6 months) and the long-term (36 months) periods, the mean predicted probability of ETV for the patients with successful ETV treatment was significantly higher than in the patients with failed ETV treatment. The areas under the curve for the short- and long-term periods were, respectively, 0.82 (95% CI 0.71-0.92) and 0.73 (95% CI 0.62-0.84). For patients with moderate ETVSS (50-70), the median age at first ETV was significantly higher for patients with successful ETV for both short- and long-term periods. CONCLUSION: In hydrocephalic children, the ETVSS is a useful tool for prediction of outcome after ETV treatment. The ETVSS is more adequate in predicting short-term than long-term success. In our population, it is suggested that success rate for patients with moderate ETVSS could be improved if more weight is attributed to age at first ETV.
Authors: Abhaya V Kulkarni; James M Drake; John R W Kestle; Conor L Mallucci; Spyros Sgouros; Shlomi Constantini Journal: J Neurosurg Pediatr Date: 2010-10 Impact factor: 2.375
Authors: V Siomin; H Weiner; J Wisoff; G Cinalli; A Pierre-Kahn; C Saint-Rose; R Abbott; H Elran; L Beni-Adani; G Ouaknine; S Constantini Journal: Childs Nerv Syst Date: 2001-09 Impact factor: 1.475
Authors: Abhaya V Kulkarni; James M Drake; Conor L Mallucci; Spyros Sgouros; Jonathan Roth; Shlomi Constantini Journal: J Pediatr Date: 2009-05-15 Impact factor: 4.406
Authors: Leopoldo Mandic Ferreira Furtado; José Aloysio da Costa Val Filho; Eustaquio Claret Dos Santos Júnior Journal: Neurosurg Rev Date: 2021-01-03 Impact factor: 3.042
Authors: José Aloysio da Costa Val Filho; Sebastião Nataniel da Silva Gusmão; Leopoldo Mandic Ferreira Furtado; Guaracy de Macedo Machado Filho; Fernando Levi Alencar Maciel Journal: Neurosurg Rev Date: 2021-02-23 Impact factor: 3.042
Authors: Sondre Tefre; Alexander Lilja-Cyron; Lisa Arvidsson; Jiri Bartek; Alba Corell; Axel Forsse; Andreas Nørgaard Glud; Sami Abu Hamdeh; Frederik Lundgaard Hansen; Antti Huotarinen; Conny Johansson; Olli-Pekka Kämäräinen; Tommi Korhonen; Anna Kotkansalo; Nadia Mauland Mansoor; Eduardo Erasmo Mendoza Mireles; Rares Miscov; Sune Munthe; Henrietta Nittby-Redebrandt; Nina Obad; Lars Kjelsberg Pedersen; Jussi Posti; Rahul Raj; Jarno Satopää; Nils Ståhl; Sami Tetri; Lovisa Tobieson; Marianne Juhler Journal: BMJ Open Date: 2022-01-31 Impact factor: 2.692